T A Gudasheva Selected Research

T A Gudasheva Research Topics

Disease

6	Schizophrenia (Dementia Praecox) 01/2012 - 11/2003
5	Hyperglycemia 12/2019 - 01/2013
5	Ischemia 08/2019 - 02/2011
5	Alzheimer Disease (Alzheimer's Disease) 01/2015 - 01/2005
4	Weight Loss (Weight Reduction) 10/2020 - 01/2013
4	Brain Ischemia (Cerebral Ischemia) 07/2019 - 09/2000
3	Type 2 Diabetes Mellitus (MODY) 05/2022 - 04/2017
3	Hyperalgesia 11/2020 - 01/2015
3	Stroke (Strokes) 07/2019 - 02/2011
3	Hypoxia (Hypoxemia) 02/2015 - 10/2000
3	Pheochromocytoma 01/2014 - 10/2007
3	Neuroblastoma 01/2014 - 01/2012
3	Inflammation (Inflammations) 01/2012 - 03/2002
3	Infarction (Infarctions) 01/2012 - 02/2011
2	Diabetes Mellitus 05/2022 - 04/2018
2	Brain Injuries (Brain Injury) 07/2019 - 01/2012
2	Body Weight (Weight, Body) 04/2018 - 01/2013
2	Ischemic Stroke 12/2017 - 01/2012
2	Heart Arrest (Cardiac Arrest) 08/2015 - 04/2015
2	Hypercapnia 02/2015 - 01/2012
2	Catalepsy 10/2011 - 01/2002
2	Parkinsonian Disorders (Parkinsonism) 10/2011 - 10/2003
1	Diabetic Neuropathies (Diabetic Neuropathy) 05/2022
1	Visceral Pain 04/2021
1	Mental Disorders (Mental Disorder) 01/2021
1	Opioid-Related Disorders (Opiate Addiction) 11/2020
1	Shock 06/2020
1	Myocardial Infarction 03/2020
1	Neurodegenerative Diseases (Neurodegenerative Disease) 02/2020
1	Prediabetic State (Prediabetes) 12/2019
1	Hyperhomocysteinemia 08/2019
1	Myocardial Ischemia (Ischemic Heart Diseases) 08/2019
1	Polydipsia 01/2019
1	Hyperphagia (Overeating) 01/2019
1	Dementia (Dementias) 04/2017
1	Amnesia (Dissociative Amnesia) 07/2015
1	Hematoma 03/2013
1	Hemorrhagic Stroke 03/2013
1	Thrombosis (Thrombus) 01/2013
1	Edema (Dropsy) 03/2011
1	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 03/2011

Drug/Important Bio-Agent (IBA)

20	DipeptidesIBA 06/2020 - 09/2000
13	Nerve Growth Factor (NGF)IBA 05/2022 - 02/2011
8	Streptozocin (Streptozotocin)FDA Link 05/2022 - 01/2013
6	Nerve Growth Factors (Neurotrophins)IBA 01/2021 - 09/2008
6	ethyl phenylacetyl-Pro-GlyIBA 12/2019 - 03/2001
5	Lysine (L-Lysine)FDA Link 05/2022 - 01/2012
5	GZR 123IBA 01/2012 - 11/2003
4	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2021 - 04/2018
4	Pharmaceutical PreparationsIBA 01/2012 - 03/2002
3	Hypoglycemic Agents (Hypoglycemics)IBA 05/2022 - 01/2013
3	bis- (N- monosuccinyl- l- seryl- l- lysine)hexamethylenediamideIBA 11/2020 - 07/2013
3	cyclo(prolylglycyl)IBA 03/2016 - 01/2012
3	NeurotoxinsIBA 07/2013 - 10/2003
3	Neuroprotective AgentsIBA 07/2013 - 09/2002
3	CarrageenanIBA 01/2012 - 03/2002
3	Antipsychotic Agents (Antipsychotics)IBA 09/2009 - 01/2005
2	Glucose (Dextrose)FDA LinkGeneric 05/2022 - 10/2000
2	Glutamic Acid (Glutamate)FDA Link 03/2016 - 09/2009
2	Scopolamine (Hyoscine)FDA Link 07/2015 - 03/2005
2	Apomorphine FDA Link 01/2012 - 01/2002
2	1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA 03/2011 - 10/2007
1	Acetic Acid (Vinegar)FDA LinkGeneric 04/2021
1	2- (4- morpholinyl)- 8- phenyl- 4H- 1- benzopyran- 4- oneIBA 10/2020
1	Metalloproteases (Metalloproteinases)IBA 03/2020
1	Doxycycline (Periostat)FDA LinkGeneric 03/2020
1	Proline (L-Proline)FDA Link 03/2020
1	ZincIBA 02/2020
1	DNA (Deoxyribonucleic Acid)IBA 12/2019
1	Malondialdehyde (Propanedial)IBA 12/2019
1	Methionine (L-Methionine)FDA Link 08/2019
1	Trimetazidine (Vastarel)IBA 08/2019
1	Isoproterenol (Isoprenaline)FDA LinkGeneric 08/2019
1	Ranolazine FDA Link 08/2019
1	Therapeutic UsesIBA 07/2019
1	Metformin (Glucophage)FDA LinkGeneric 01/2019
1	emoxypine succinateIBA 12/2017
1	NeuropeptidesIBA 03/2016
1	Nootropic Agents (Nootropics)IBA 07/2015
1	Anti-Anxiety Agents (Anxiolytics)IBA 07/2015
1	Glutamine (L-Glutamine)FDA Link 03/2013
1	DiamideIBA 03/2013
1	N-Methylaspartate (NMDA)IBA 01/2012
1	Oxidopamine (6 Hydroxydopamine)IBA 01/2012
1	Concanavalin AIBA 01/2012
1	Ketamine FDA LinkGeneric 01/2012
1	Piracetam (Nootropil)IBA 01/2012
1	Diclofenac (SR 38)FDA LinkGeneric 01/2012
1	Dopamine (Intropin)FDA LinkGeneric 01/2012
1	Haloperidol (Haldol)FDA LinkGeneric 10/2011
1	triphenyltetrazoliumIBA 09/2011
1	GB-115IBA 03/2011
1	AmidesIBA 03/2011
1	glycyltryptophanIBA 03/2011

Therapy/Procedure

5	Therapeutics 05/2022 - 10/2007
5	Intraperitoneal Injections 01/2012 - 02/2011
3	Oral Administration 10/2011 - 09/2000
2	Resuscitation 08/2015 - 04/2015
2	Injections 01/2012 - 03/2005
1	Aftercare (After-Treatment) 07/2013